HuGE Literature Finder
Records
1
-
7
Prevalence and significance of M541L single nucleotide polymorphism in the central European cohort of gastrointestinal stromal tumor patients. Journal of cancer research and clinical oncology 2020 Oct . Jasek Karin, Grendar Marian, Stanclova Andrea, Malicherova Bibiana, Kasubova Ivana, Burjanivova Tatiana, Szepe Peter, Ciccocioppo Rachele, Rodrigo Luis, Prosecky Robert, Kruzliak Peter, Plank Lukas, Lasabova Zo |
A phase II study of a human anti-PDGFRa monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors. Annals of oncology : official journal of the European Society for Medical Oncology 2017 Mar 28 (3): 541-546. Wagner A J, Kindler H, Gelderblom H, Schöffski P, Bauer S, Hohenberger P, Kopp H-G, Lopez-Martin J A, Peeters M, Reichardt P, Qin A, Nippgen J, Ilaria R L, Rutkowski |
Correlation of Merkel cell polyomavirus positivity with PDGFRa mutations and survivin expression in Merkel cell carcinoma. Journal of dermatological science 2015 Jul 79 (1): 43-9. Batinica M, Akgül B, Silling S, Mauch C, Zigrino |
The outcome of targeted therapy in advanced gastrointestinal stromal tumors (GIST) with non-exon 11 KIT mutations. Polski przeglad chirurgiczny 2014 Jul 86 (7): 325-32. Osuch Czes?aw, Rutkowski Piotr, Brzuszkiewicz Karolina, Bylina El?bieta, Limon Janusz, Siedlecki Janusz |
Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors. BMC medicine 2010 8 (1): 26. Silva Mara, Veiga Isabel, Ribeiro Franclim R, Vieira Joana, Pinto Carla, Pinheiro Manuela, Mesquita Bárbara, Santos Catarina, Soares Marta, Dinis José, Santos Lúcio, Lopes Paula, Afonso Mariana, Lopes Carlos, Teixeira Manuel |
Homozygous deletion of MTAP gene as a poor prognosticator in gastrointestinal stromal tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Nov 15 (22): 6963-72. Huang Hsuan-Ying, Li Shau-Hsuan, Yu Shih-Chen, Chou Fong-Fu, Tzeng Ching-Cherng, Hu Tsung-Hui, Uen Yih-Huei, Tian Yu-Fang, Wang Yu-Hui, Fang Fu-Min, Huang Wen-Wei, Wei Yu-Ching, Wu Jing-Mei, Li Chien-Fe |
A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor. Oncology 2009 Mar 76 (5): 5. Ryu MH, Kang WK, Bang YJ, Lee KH, Shin DB, Ryoo BY, Roh JK, Kang JH, Lee H, Kim TW, Chang HM, Park JO, Park YS, Kim TY, Kim MK, Lee WK, Kang HJ, Kang YK |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 27, 2022
- Content source: